Diagnosis strategies in activated protein C resistance: Is genotyping still necessary?

Clinical and Laboratory Haematology

Volumn 19, Issue 1, 1997, Pages 67-71

  Biron, C ^a   Lamarti, H ^a   Schved, J F ^a   Jeanjean, P ^a   Masmejean, C ^a   Claustres, M ^b   Aguilar Martinez, P ^a  

^a HÔPITAL SAINT ELOI   (France)

^b Institute of Biology   (France)

Author keywords

Activated protein C resistance; Denaturing gradient gel electrophoresis; Diagnosis strategy; Factor V; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOSIS;

EID: 0030977193     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1997.00209.x     Document Type: Article

References (18)

1. Bertina R.M., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., van de Veldon P.A. & Reitsma P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67.
2. Gumming A.M., Campbell Tait R., Fildes S. & Hay C.R.M. (1996) Diagnosis of APC resistance during pregnancy. British Journal of Haematology 92, 1026-1027.
3. Dahlbäck B. (1995) Resistance to activated protein C, the Arg506 to gin mutation in the factor V gene, and venous thrombosis. Functional test and DNA-based assays, pros and cons. Thromb. Haem. 73, 739-742.
4. Dahlbäck B., Carlsson M. & Svensson P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proceedings of the National Academy of Science of the USA 90, 1004-1008.
5. Engel H. Zwang L., van Vliet H.H.D.M., Michiels J.J., Stibbe J. & Lindemans J. (1996) Phenotyping and genotyping of Factor V Thromb. Haemost 75, 267-269.
6. Gandrille S., Greengard J.S., Alhenc-Gelas M., Juhan-Vague I., Abgrall J.F., Jude B., Griffin J.H. & Aiach M. (1995) Incidence of activated protein C resistance caused by the Arg 506 Gln mutation in factor Vin 113 unrelated symptomatic protein C-deficient patients. Blood 86, 219-224.
7. Gilmore G., Thom J. & Baker R.I. (1996) Diagnosis of APC resistance in patients on standard or low molecular weight heparin. Thromb Haemost 75, 372-373.
8. Gschwandter M.E., Lechner K. & Pabinger I. (1995) Erroneously low APC ratio in patients with lupus anticoagulant. Annls of Hematology, 169-170.
9. Jorquera J.I., Montoro J.M., Fernazndez M.A., Aznar J.A. & Aznar J. (1994). Modified test for activated protein C resistance. Lancet 344, 1162-1163.
10. Mandel H., Brenner B., Berant M., Rosenberg N., Lanir N., Jakobs C., Fowler B. & Seligsohn U. (1996) Coexistence of hereditary homocystinuria and factor Leiden-effect on thrombosis. New England Journal of Medicine 334, 763-768.
11. Myers R.M., Fischer S.G., Lerman L.S. & Maniatis T. (1985) Nearly all single base substitutions in DNA fragments joined to a GC clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acids Research 13, 3131-3145.
12. Rees D.C., Cox M. & Clegg J.B. (1995) World distribution of factor V Leiden, Lancet 356, 1133-1134.
13. Roelse J.C., Koopman M.M.W., Büller H.R. Ten Cate J.W., Montaruli B., van Mourik J.A. & Voorberg J. (1996) Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis. British Journal of Haematology 92, 740-743.
14. Svensson P.J. & Dalhlbäck B. (1994) Resistance to activated protein C as a basis for venous thrombosis. New England Journal of Medicine 330, 517-521.
15. Trossaërt M., Conard J. Horellou M.H., Samama M.M., Ireland H, Bayston T.A. & Lane D.A. (1994). Modified APC resistance assay for patients on oral anticoagulant. Lancet 344, 1709-1710.
16. Trossaërt M., Conard J. Horellou M.H., Elalamy I. & Samama M.M. (1996). The modified APC resistance test in the presence of Factor V deficient plasma can be used in patients without oral anticoagulant Thromb. Haemost. 75, 520-521.
17. Zöller B., Svensson P.J., He X. & Dahlbäck B. (1994) Identification of the same factor V gene mutation in 47 of 50 thrombosisprone families with inherited resistance to activated protein C. Journal of Clinical Investigation 94, 2521-2524.
18. Zöller B., Berntsdotter A., Garcia de Frutos P. & Dahlbäck B, (1995) Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 85, 3518-3523.